In this Section

Blood Disorders Program

We treat general hematology disorders such as thrombocytopenia, platelet disorders and white blood cell disorders. Our Hemophilia Treatment Center (HTC) is the only federally-funded center in the Central Valley recognized for providing comprehensive care to individuals with bleeding and clotting problems such as hemophilia, thromboembolic disorders and von Willebrand disease. We also have a hemoglobinopathy program that includes sickle cell anemia and thalassemia, a prevalent condition in the Central Valley region.

Valley Children’s is part of the Western States Region IX Hemophilia Network and the Thalassemia Western Consortium. We see more than 25 outpatient visits every day. The team performs outpatient blood, platelet and immune-globulin transfusions for our pediatric patients who require these regimens.

As one of the 140 HTCs in the nation, we contribute to many research initiatives including My Life Our Future (MLOF) and the Centers for Disease Control’s (CDC) ongoing Universal Data Collection project, which benefits our bleeding disorder patients. The treatment center has participated in the CDC blood safety and surveillance study since 2001. Our hematology team originated “Genotyping Days” for enrolling people with hemophilia A or B and potential carriers to MLOF’s research repository.

Our hematologists also work with experts across the country to offer some of the newest treatments available for thalassemia, sickle cell disease and iron overload.

To view the full range of the conditions we treat, please visit our Conditions We Treat page.

Learn more about:
Hemophilia in children
Bleeding disorders
Sickle cell

Adult Hematology Services

Valley Children’s also treats adult patients with blood disorders. We partner with California Cancer Associates for Research & Excellence (cCare) to perform outpatient blood and transitional hematologic care to adolescent and adult patients of all ages.